Refractory Transformed Non-Hodgkin Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11595 | Atezolizumab | 1 | Active Not Recruiting | 1 |
DB05015 | Belinostat | 1 | Recruiting | 1 |
DB00441 | Gemcitabine | 1 | Active Not Recruiting | 1 |
DB00526 | Oxaliplatin | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 1 | Active Not Recruiting | 1 |
DB12887 | Tazemetostat | 1 | Recruiting | 1 |
DB02546 | Vorinostat | 1 | Active Not Recruiting | 1 |
DB02379 | Beta-D-Glucose | 1 / 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 / 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB00773 | Etoposide | 1 / 2 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
DB01181 | Ifosfamide | 1 / 2 | Active Not Recruiting | 1 |
DB00480 | Lenalidomide | 1 / 2 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 1 / 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB16582 | Lisocabtagene maraleucel | 2 | Recruiting | 1 |
DB06306 | Onalespib | 2 | Terminated | 1 |
DB15035 | Zanubrutinib | 2 | Recruiting | 1 |